Enzychem Lifesciences Corporation
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Enzychem Lifesciences Corporation
Plus deals involving Astellas/Menarini, Maruho/Fortress Biotech, Zenas/Bristol Myers Squibb, Huadong Medicine/MC2 and more.
Sino acquires Gmax's obesity drug candidate. Simcere partners with Mass General Brigham on select research projects.
Transactions involving Biocon/Zentiva, CrystalGenomics/PanGen, Umoja/IASO, Marinus/Tenacia, Ono/Captor and Daewoong/HitGen plus deals in brief.
Five Chinese bioventures have raised more than $70m from venture capital and private equity funds since late May.
- Other Names / Subsidiaries
- Enzychem Lifesciences USA
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.